According to the World Health Organization (WHO), lenacapavir offers a highly effective, long-acting alternative to daily ...

For over three decades, HIV has played an elaborate game of hide-and-seek with researchers, making treating-and possibly even ...

Year's supply of injectable to cost Rs 3,549, compared to over Rs 17 lakh in US. Powerful alternative to daily oral PrEP, ...

In his first term, President Trump pledged to boost HIV spending, with the lofty goal of bringing the epidemic to heel by ...

Cork and Kerry share one HIV clinic, which is 'stretched', Cork Sexual Health Centre's fast-track cities programme manager ...

Lots of scholarship assumes that partners in higher-quality relationships work together to reduce health-related risks. A new study tested this assumption.

For over three decades, HIV has played an elaborate game of hide-and-seek with researchers, making treating—and possibly even ...

From 2027, Indian generics companies and Hetero Labs Dr. Reddy's will supply lenacapavir, a twice-yearly injectable PrEP with ~96-100% efficacy, for US$40 (R698) per person per year across 120 low- ...

Key points On Jan. 20, 2025, the incoming United States administration froze all foreign assistance funds for 90 days, including the President’s Emergency Plan for AIDS Relief (PEPFAR) funding.[1][1] ...

Indian generic manufacturers will produce lenacapavir, a near 100% effective, six-month injectable HIV prevention drug, ...

This scenario of opaque pricing, restrictive licensing and inadequate global targets will leave far too many people at continued risk of preventable HIV ...